http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-365035-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30432c021c19453629a3b69ce104640e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-23 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-50 |
filingDate | 1969-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1971-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-365035-A1 |
titleOfInvention | PROCEDURE FOR THE PRODUCTION OF N1- (4-AMINO-2-HYDROXY-BUTYRIL) -4-O- (2,6-DIAMINE-2,6-CLIDEOXY-D-GLICOPYRANOSIL) -5- OD-XYLOPHURANOSIL-2-DEOXYSTREPTAMINE , N1- (4-AMINO-2-HYDROXIBUTYRIL) -4-O- (2,6-DIAMINE-2,6-DIDEOXY-D-GLUCOPYRANE. |
abstract | The novel antibiotic ambutyrosin comprises a major proportion by weight of ambutyrosin A of formula and a minor proportion by weight of ambutyrosin B of formula and is prepared by cultivating an ambutyrosinproducing strain of Bacillus circulans, e.g. those identified by the numbers NRRL B-3312 and NRRL B-3313. The ambutyrosin may be obtained in the form of its salts and may be separated into the components A and B by known methods. The tetra-N-acetyl derivatives are also prepared. |
priorityDate | 1968-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.